New drug NRS 033 tested in healthy people for first time
Knowledge-focused
Completed
This early-stage study tested a single dose of the experimental drug NRS 033 in 24 healthy adults aged 18 to 55. The main goal was to check safety and how the drug moves through the body. No treatment was given for any disease, so this study does not offer any direct health benef…
Phase: PHASE1 • Sponsor: Nirsum Labs • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC